Stifel Financial Corp Has $673,000 Holdings in National Research Co. (NASDAQ:NRC)

Stifel Financial Corp decreased its holdings in shares of National Research Co. (NASDAQ:NRC) by 8.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 29,433 shares of the company’s stock after selling 2,737 shares during the quarter. Stifel Financial Corp owned approximately 0.12% of National Research worth $673,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Bank of New York Mellon Corp boosted its position in National Research by 5.4% during the second quarter. Bank of New York Mellon Corp now owns 123,255 shares of the company’s stock valued at $2,829,000 after purchasing an additional 6,295 shares during the last quarter. Rhumbline Advisers raised its position in National Research by 4.3% during the second quarter. Rhumbline Advisers now owns 21,453 shares of the company’s stock worth $492,000 after acquiring an additional 892 shares in the last quarter. American Century Companies Inc. lifted its stake in National Research by 13.3% in the second quarter. American Century Companies Inc. now owns 31,231 shares of the company’s stock valued at $717,000 after acquiring an additional 3,657 shares during the last quarter. Renaissance Technologies LLC grew its position in shares of National Research by 14.4% in the 2nd quarter. Renaissance Technologies LLC now owns 432,884 shares of the company’s stock valued at $9,935,000 after acquiring an additional 54,600 shares during the period. Finally, Benjamin F. Edwards & Company Inc. increased its stake in shares of National Research by 145.6% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 2,783 shares of the company’s stock worth $64,000 after purchasing an additional 1,650 shares during the last quarter. Institutional investors own 47.26% of the company’s stock.

National Research Trading Down 0.4 %

Shares of NASDAQ:NRC opened at $17.76 on Thursday. National Research Co. has a 52-week low of $16.74 and a 52-week high of $42.18. The company has a debt-to-equity ratio of 1.30, a quick ratio of 0.47 and a current ratio of 0.47. The company has a market capitalization of $416.93 million, a P/E ratio of 15.72 and a beta of 0.52. The company has a 50-day simple moving average of $18.88 and a 200 day simple moving average of $21.28.

National Research (NASDAQ:NRC) last issued its earnings results on Friday, October 25th. The company reported $0.24 EPS for the quarter. National Research had a return on equity of 67.40% and a net margin of 18.78%. The company had revenue of $35.82 million during the quarter.

National Research Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Friday, December 27th will be paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.70%. The ex-dividend date is Friday, December 27th. National Research’s dividend payout ratio is presently 42.48%.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.